Perrigo Company PLC (PRGO) Releases Quarterly Earnings, Beats Estimates By $0.19 EPS
Perrigo Company PLC (NASDAQ:PRGO) released its earnings data on Thursday. The company reported $1.74 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.55 by $0.19, AR Network reports. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion.
Perrigo Company PLC (NASDAQ:PRGO) opened at 139.15 on Thursday. Perrigo Company PLC has a 1-year low of $115.94 and a 1-year high of $168.39. The stock’s 50-day moving average is $149.9 and its 200-day moving average is $148.9. The company has a market cap of $18.618 billion and a P/E ratio of 76.29.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 16th. Stockholders of record on Friday, August 29th will be paid a dividend of $0.105 per share. This represents a $0.42 annualized dividend and a dividend yield of 0.30%.
PRGO has been the subject of a number of recent research reports. Analysts at Deutsche Bank initiated coverage on shares of Perrigo Company PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $189.00 price target on the stock. Analysts at Morgan Stanley downgraded shares of Perrigo Company PLC from an “overweight” rating to an “equal weight” rating in a research note on Friday, July 11th. Three investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $166.25.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.